KOHJIN BIO CO LTD (177A.T)

JPY 1703.0

(-0.12%)

Annual Income Statements

(In JPY)
Breakdown 2024 2023 2022
Revenue 4.77 Billion 4.74 Billion 3.94 Billion
Cost of Revenue 2.88 Billion 2.28 Billion 1.9 Billion
Gross Profit 1.88 Billion 2.45 Billion 2.03 Billion
Operating Expenses 1.28 Billion 1.18 Billion 1.06 Billion
Selling, General and Administrative Expenses -1000.00 1.18 Billion 1.06 Billion
Research and Development Expenses - - -
Other Expenses 1.28 Billion 3.57 Million 10.91 Million
Cost and Expenses 4.17 Billion 3.47 Billion 2.97 Billion
Operating Income 596.82 Million 1.26 Billion 969.58 Million
Interest Expense 22.87 Million 32.46 Million 38.94 Million
Income Tax Expense 250.62 Million 414.54 Million 334.38 Million
Earnings before Tax 635.6 Million 1.24 Billion 922.06 Million
Net Income 384 Million 829.79 Million 587.67 Million
Earnings Per Share Basic 92.20 199.23 117.18
Earnings Per Share Diluted 92.20 199.23 117.18
Weighted Average Shares Outstanding 4.16 Million 4.16 Million 5.01 Million
Weighted Average Shares Outstanding (Diluted) 4.16 Million 4.16 Million 5.01 Million
Gross Margin 0.39 0.52 0.52
EBIT Margin 0.20 0.30 0.29
Profit Margin 0.08 0.17 0.15
EBITDA 958.1 Million 1.44 Billion 1.14 Billion
Earnings Before Tax Margin 0.13 0.27 0.25

Income Statement Charts